Michael Allen Jerman Insider Profile
4 Followers
Michael Allen Jerman, Director at Alaunos Therapeutics, holds 23.76K shares in Alaunos Therapeutics (Ticker: TCRT), holds ― shares in MIRA Pharmaceuticals, Inc. (Ticker: MIRA), holds 180.41K shares in Inhibitor Therapeutics (Ticker: INTI).
Michael Allen Jerman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Allen Jerman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Allen Jerman
Michael Allen Jerman's Trading History
Alaunos Therapeutics
Jul 27, 2026
Director
Uninformative Buy
15.62K
$35.88K
MIRA Pharmaceuticals, Inc.
―
Director
―
―
Inhibitor Therapeutics
Jun 24, 2026
Director
Uninformative Buy
―
$18.04K
Telomir Pharmaceuticals, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Michael Allen Jerman's performance on stock
You May Also Like
Michael Allen Jerman insider profile FAQ
What is the percentage of profitable transactions made by Michael Allen Jerman?
The percentage of profitable transactions made by Michael Allen Jerman is ―.
What is the average return per transaction made by Michael Allen Jerman?
The average return per transaction made by Michael Allen Jerman is ―.
What stocks does Michael Allen Jerman hold?
Michael Allen Jerman holds: TCRT, MIRA, INTI, TELO stocks.
What was Michael Allen Jerman’s latest transaction?
Michael Allen Jerman latest transaction was an Uninformative Buy of $15.62K.
What was Michael Allen Jerman's most profitable transaction?
Michael Allen Jerman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Allen Jerman's role in Alaunos Therapeutics?
Michael Allen Jerman's role in Alaunos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.